MT-2 (Melanotan II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that has been extensively studied in preclinical models for its interactions with the melanocortin receptor system. Research into MT-2 nasal spray delivery formats has grown substantially as investigators explore how transmucosal administration may influence the pharmacokinetic profile of this compound compared to […]

BPC-157 adverse event research has become one of the most actively queried areas in peptide biology, as investigators seek to understand how this synthetic pentadecapeptide behaves across a range of preclinical model systems. Derived from a sequence found in gastric juice proteins, BPC-157 has been the subject of numerous laboratory investigations examining not only its […]

TB-500, the synthetic analogue of Thymosin Beta-4, has attracted sustained attention in peptide research due to its involvement in actin-binding dynamics and tissue-level biology. As preclinical investigations expand, researchers have increasingly turned their focus to a fundamental question in peptide pharmacology: TB-500 oral bioavailability. Understanding how this peptide behaves when introduced via gastrointestinal routes — […]

Budget planning is a genuine consideration for any research program, and identifying high-value research peptides under $100 can meaningfully expand what a laboratory is able to investigate without compromising on compound quality or scientific breadth. The peptide research landscape in 2026 includes a remarkably diverse range of mechanisms — from growth hormone secretagogue biology and […]

PT-141, also known as bremelanotide, is a synthetic melanocortin peptide that has attracted significant interest in preclinical research settings due to its interaction with melanocortin receptor subtypes — particularly MC3R and MC4R. As laboratory investigation of this compound has expanded, researchers have increasingly focused not just on the peptide’s receptor biology, but on how delivery […]

GLP-3 (R) represents one of the most structurally sophisticated compounds under active investigation in metabolic peptide research. As a triple receptor agonist designed to engage GLP-1 receptors, GIP receptors, and glucagon receptors simultaneously, GLP-3 (R) occupies a unique position in the landscape of incretin-related research peptides. Studies have investigated how this simultaneous multi-receptor engagement produces […]

Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide that has attracted significant scientific interest across multiple research disciplines. First isolated from porcine intestinal tissue in 1970, VIP peptide research has since expanded to explore its roles in neuroimmune signaling, smooth muscle biology, and circadian rhythm regulation. Its broad receptor expression and multi-system activity make […]

The regulatory landscape surrounding peptides underwent significant changes in 2025 and into 2026, reshaping how researchers, laboratories, and procurement teams approach peptide acquisition and study design. Understanding the FDA’s current classification framework — particularly the distinction between Category 1 peptides subject to compounding restrictions and those that remain accessible for legitimate laboratory research — is […]

BPC-157 nasal spray has emerged as a prominent format of interest among peptide researchers investigating mucosal delivery biology and the systemic distribution of body protection compound 157. As a synthetic pentadecapeptide originally derived from a gastric juice protein sequence, BPC-157 has been the subject of extensive preclinical investigation across multiple tissue systems. The nasal spray […]

The BPC-157 and TB-500 Wolverine stack has emerged as one of the most studied peptide combinations in preclinical tissue biology research. Each compound individually carries a substantial body of published preclinical literature, but the combination — frequently referred to in research circles as the “Wolverine” formulation — has drawn increasing scientific attention for its potential […]